Mirae Asset Global ETFs Holdings’s Beam Therapeutics BEAM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.79M	Buy	118,018 +5,247	+5%	+$146K	﹤0.01%	1040
2025 Q4	$3.13M	Buy	112,771 +4,090	+4%	+$104K	﹤0.01%	967
2025 Q3	$2.64M	Sell	108,681 -8,765	-7%	-$174K	﹤0.01%	1022
2025 Q2	$2M	Sell	117,446 -49,568	-30%	-$863K	﹤0.01%	1101
2025 Q1	$3.28M	Buy	167,014 +4,607	+3%	+$121K	0.01%	894
2024 Q4	$4.03M	Buy	162,407 +6,128	+4%	+$156K	0.01%	845
2024 Q3	$3.83M	Sell	156,279 -17,901	-10%	-$462K	0.01%	850
2024 Q2	$4.08M	Buy	+174,180	New	+$4.28M	0.01%	812

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BEAM Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Beam Therapeutics (BEAM) stake by 4.7% in Q1 2026, buying an estimated $146K and bringing the position to 118,018 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1040.

Mirae Asset Global ETFs Holdings first reported a position in BEAM in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.08M in Q2 2024. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

Mirae Asset Global ETFs Holdings held 118,018 shares of Beam Therapeutics worth $2.79M as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 5,247 Beam Therapeutics shares in Q1 2026, an estimated $146K.
Beam Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1040 holding.
Mirae Asset Global ETFs Holdings first reported a position in Beam Therapeutics in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Beam Therapeutics position peaked at $4.08M in Q2 2024.
251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.